Skylight Health to Host Virtual KOL Event Focusing on the US Healthcare Market
- Wall Street ends week positively; S&P 500, Dow hit record highs
- Bitcoin (BTC) Drops 3% as Turkey Bans Cryptocurrency Payments Citing Lack of Regulatory Supervision
- Morgan Stanley (MS) Archegos-Related Loss Appears to be $911M
- Dollar at 4-week low on retreating Treasury yields
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
TORONTO, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), one of the largest multi-specialty healthcare systems in the United States, today announced that they will host a virtual Key Opinion Leader (KOL) event on the Future of Healthcare in the US.
The Skylight Health Virtual KOL Event details as follows:
Thursday, February 25, 20211:00 - 3:30 PM EST
To join the meeting using Webex, click the link here.
To join by phone, Canadian callers can use 1-647-484-1598 and US callers can use 1-415-655-0001.
Meeting number (access code): 182 213 3621Meeting password: shgff (dial 74433 from phones or video systems)
A corporate overview will be presented, followed by 3 fireside chats.
|•||1:00PM Corporate Presentation: Prad Sekar, Co-Founder and CEO|
|•||1:30PM Future of Payment Models & Importance of Primary Care: Featuring Dr. Georges Feghali (Chief Medical Officer for Skylight Health, formerly with TriHealth) and Jerry Oliphant (Chief Operating Officer for Skylight Health, formerly with Cleveland Clinic)|
|•||2:00PM Case Study: NASDAQ Listing Opportunity Featuring Michael Salaman (President and Co-Founder of GrowGeneration Corp, a US$3.2B NASDAQ listed company) and hosted by Jeff Monat (Partner, New York-based private equity firm, Merida Capital Holdings)|
|•||2:30PM The Future of Telemedicine and Data in Healthcare: Chris Smith (SVP Digital Health at Skylight Health) and Paul Kulas (SVP of Operations at Skylight Health). Hosted by Rob Goff (Managing Director, Echelon Wealth Partners: Head of Research, Technology, Special Situations)|
|•||3:00PM Investor Questions|
“Our 2021 KOL event provides an opportunity for participants to interact with some of the most innovative minds in United States healthcare. We look forward to inspiring insightful conversations about the future of the industry that will offer our shareholders and supporters new perspectives,” noted Prad Sekar, CEO and Co-Founder of Skylight Health.
Skylight Health hosted a Special Meeting of Shareholders on Monday, February 22, 2021. We have received the required shareholder approval for all proposed resolutions. As per the proposal, the Company has been granted, in relation to its NASDAQ application, the option to consolidate shares up to 5:1 and will determine the appropriate action based on best interest of shareholders, current share price, and NASDAQ listing requirements. The Company will announce any material changes to any share structure as it becomes necessary.
About Skylight Health GroupSkylight Health Group (TSXV:SHG; OTCQX: SHGFF) is a healthcare services and technology company, working to positively impact patient health outcomes. The Company operates a US multi-state health network that comprises of physical multi-disciplinary medical clinics providing a range of services from primary care, sub-specialty, allied health and laboratory/diagnostic testing. The Company owns and operates a proprietary electronic health record system that supports the delivery of care to patients via telemedicine and other remote monitoring system integrations. With a patient roster of over 155,000 patients, the Company’s operations servicing 16 states and continues to expand in services and locations both organically and by way of strategic acquisitions.
The Company primarily operates a traditional insurable fee-for-service model contracting with Medicare, Medicaid and other Commercial Payors. The Company also offers a disruptive subscription-based telemedicine service for the un/under-insured population who have limited access to urgent care due to cost.
For more information, please visit www.skylighthealthgroup.com or contact:
Investor Relations:Jackie Kellyinvestors@skylighthealthgroup.com416-301-2949
Currency Usage, Cautionary and Forward-Looking Statements
All currency contained in this Press Release represent Canadian Dollars unless otherwise stated.
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Skylight Health's filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.
Forward-looking statements may include, without limitation, statements regarding the Company's unaudited financial results and projected growth.
Financial forecasts in this release are based on the current revenue run rate of Skylight Health, all of its recently completed acquisitions, and its pending acquisitions. This forecast is subject to the closing of any and all pending acquisitions, and successful integration of all its current and future acquisitions without any loss or interruptions of revenues during the integration and transition process. The Company may revise this forecast from time to time and investors should not solely rely on this forward-looking guidance when making an investment decision.
Although Skylight Health has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: the ability of Skylight Health to execute on its business strategy, continued revenue growth in accordance with management’s expectations, operating expenses continuing in accordance with management expectations, dependence on obtaining regulatory approvals; Skylight Health being able to find, complete and effectively integrate target acquisitions; change in laws relating to health care regulation; reliance on management; requirements for additional financing; competition; hindering market growth or other factors that may not currently be known by the Company.
There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Skylight Health disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Skylight Health does not assume any liability for disclosure relating to any other company mentioned herein.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CytoDyn Submits First and Most Crucial Section (CMC) of Interim Order Application to Health Canada for COVID-19 Under Rolling Review
- NXT Energy Solutions Announces Acquisition of Geothermal Rights
- Augumenta Helps JICA Deliver Remote Learning Collaboration to Developing Countries Using Smart Glasses